|
US2019060250A1
|
|
Method to treat psoriasis
|
|
US2019060251A1
|
|
Method to treat atopic dermatitis
|
|
US2019060252A1
|
|
Method to treat vitiligo
|
|
EP3488220A1
|
|
Chewing gum composition comprising cannabinoids and gabapentin
|
|
WO2018075730A1
|
|
Suppositories comprising cannabinoids
|
|
WO2018075665A1
|
|
Chewing gum composition comprising cannabinoids and opioid agonists and/or antagonists
|
|
EP3448521A1
|
|
Chewing gum composition comprising cannabinoids and nicotine
|
|
EP3313394A1
|
|
Anti-microbial compositions comprising cannabinoids
|
|
US2016374958A1
|
|
Anti-microbial composition comprising cannabinoids
|
|
US2016326130A1
|
|
Process to extract and purify Δ9-tetrahydrocannabinol
|
|
WO2016133824A1
|
|
Cosmetic and topical compositions comprising cannabigerol
|
|
EP3253368A1
|
|
Cannabinoid and sugar alcohol complex, methods to make and use
|
|
EP3240535A1
|
|
Ophthalmic solutions for glaucoma and conjunctivitis treatment
|
|
US2016166498A1
|
|
Oral care composition comprising cannabinoids
|
